Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Psychometric Evaluation of the Migraine-Specific Quality of Life Questionnaire (MSQ v2.1) Using Data From Phase 3 Clinical Trials in Patients With Chronic Migraine (CM) and Episodic Migraine (EM)

              Author:Stokes, Jonathan   Dodick, David   Lipton, Richard   Whalley, Diane   Savva, Yulia   Gelhorn, Heather   Nelson, Lauren   Yarr, Stuart   Gandhi, Pranav   

              Session Name:P8: Headache: Innovation, Quality and Technology  

              Topic:Headache  

              Program Number:P8.007  

              Author Institution:AbbVie, Madison, NJ  Mayo Clinic, Scottsdale, AZ  Albert Einstein College of Medicine, Bronx, NY  RTI Health Solutions, Manchester, United Kingdom  Evidera, Bethesda, MD  RTI Health Solutions, Research Triangle Park, NC  

              The Many Manifestations of Rhino-Orbital-Cerebral Mucormycosis: An Illustrative Case Report

              Author:Trenz, Megan   Tetreault, Lindsay   

              Session Name:P10: Infectious Disease: Noncryptococcal Fungal Infections  

              Topic:Infectious Disease  

              Program Number:P10.003  

              Author Institution:NYU Langone Hospital - Brooklyn, Brooklyn, NY  NYU Langone, Brooklyn, NY  

              Overlapping and Distinguishing Features Among MS, NMOSD, MOGAD and Other Atypical Demyelinating Syndromes of the Central Nervous System

              Author:Gulec, Bade   Cam, Abdulsamet   Bilge, Ugur   Tutuncu, Melih   Saip, Sabahattin   Uygunoglu, Ugur   Siva, Aksel   

              Session Name:P11: MS Neuroimaging 2  

              Topic:MS and Inflammatory Disease  

              Program Number:P11.016  

              Author Institution:Istanbul University Cerrahpasa-Cerrahpasa Medical Faculty, Istanbul, Turkey  Akdeniz University Faculty of Medicine, Antalya, Turkey  

              Real-World Effectiveness of Fremanezumab in Patients with Migraine who Switched From Another mAb Targeting the CGRP Pathway (Subgroup Analysis From FINESSE)

              Author:Straube, Andreas   Brössner, Gregor   Gaul, Charly   Hamann, Xenia   Hipp, Joachim   Kraya, Torsten   Schauerte, Isabel   Neeb, Lars   

              Session Name:P13: Headache: Towards Precision Medicine 3  

              Topic:Headache  

              Program Number:P13.007  

              Author Institution:Ludwig-Maximilians-University Munich, Munich, Germany  Medical University of Innsbruck, Innsbruck, Austria  Headache Center Frankfurt, Frankfurt am Main, Germany  Teva GmbH, Ulm, Germany  St. Georg Hospital/Headache Center Halle, Leipzig/Halle , Germany  Institut Dr. Schauerte, Munich, Germany  Department of Neurology, Charité Universitätsmedizin Berlin/Helios Global Health Berlin  

              Long-term Efficacy of Satralizumab in Adults with Aquaporin-4-IgG-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from SAkuraMoon

              Author:Traboulsee, Anthony   Kleiter, Ingo   Palace, Jacqueline   Fujihara, Kazuo   Saiz, Albert   Vodopivec, Ivana   Klingelschmitt, Gaelle   Marcillat, Carole   Bennett, Jeffrey   

              Session Name:S5: Autoimmune Neurology: NMOSD and MG, A Focus on Treatment Trials  

              Topic:Autoimmune Neurology  

              Program Number:S5.001  

              Author Institution:University of British Columbia, Vancouver, BC, Canada  Ruhr University Bochum, Bochum, Germany  John Radcliffe Hospital, Oxford, United Kingdom  Fukushima Medical University School of Medicine, Fukushima, Japan  University of Barcelona, Barcelona, Spain  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Colorado School of Medicine, Aurora, CO